New appointments at PriceSpective
This article was originally published in Scrip
Executive Summary
PriceSpective, a UK value strategy consultancy providing pricing and reimbursement services to pharmaceutical and biotechnology companies, has appointed Walter Colasante vice-president and Sophie Murdoch director. Mr Colasante was previously the founder and managing director of Freelance Heath Services, which specialised in pharmaceutical forecasting, business analysis and intelligence, market access planning and epidemiology. Ms Murdoch was formerly an Associate Director at Bristol-Myers Squibb, where she was responsible for developing the EMEA commercialisation strategy for Ixempra (ixabepilone).